Trametinib ameliorates aging-associated gut pathology in Drosophila females by reducing Pol III activity in intestinal stem cells is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
UKRI | Biotechnology and Biological Sciences Research Council
Grant: BB/V006541/1
Mechanisms mediating the anti-ageing effects of trametinib.
Wellcome Trust
Grant: 098565/Z/12/Z
EC | European Research Council
Grant: 268739
Experimental Research into Ageing
EC | Horizon 2020 Framework Programme
Grant: 741989
Developing Geroprotectors to Prevent Polymorbidity
Biotechnology and Biological Sciences Research Council
Grant: BB/W013525/1
Wellcome Trust
Grant: 518230
NIH HHS
Grant: P40 OD018537
Biotechnology and Biological Sciences Research Council
Grant: BB/S014357/1
National Institutes of Health
Grant: 3P40OD018537-04S1
Bloomington Drosophila Stock Center at Indiana University
Wellcome Trust
Grant: 098565
Biological determinants of ageing and late life health, and their pharmacological manipulation.
Wellcome Trust
Wellcome Trust
FWCI
2.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals